Genoverde Biosciences, Inc

Genoverde Biosciences, Inc. is an agricultural biotechnology company founded in 2015 and headquartered in Raleigh, North Carolina. The company specializes in plant genetics and bioinformatics, utilizing proprietary tissue culture technology to produce disease-free, genetically identical plantlets for commercial use. Their platform focuses on enhancing biomass yield in non-food crops through cell wall gene technology and providing services such as long-term genetic material storage, plant diagnostic testing, and soil and tissue analysis to support crop health and fertilizer optimization. The company operates research and production facilities in collaboration with institutions including Shaw University and North Carolina State University.

These capabilities are designed to help growers, breeders, and agricultural distributors maximize crop consistency and performance while protecting proprietary intellectual property. By offering an alternative to traditional propagation methods, the company aims to reduce the economic risks and technical challenges associated with maintaining mother plants over time. Their services assist clients in identifying nutrient deficiencies, monitoring for undesirable mutations, and restoring cultivars to peak performance, thereby supporting sustainable agricultural practices and yield improvements. The company has previously been the subject of federal inquiries regarding grant and loan applications, which resulted in a civil settlement in 2026.